You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Presents the complicated process of CNS drug development in a way that is engaging and informative for professionals and students.
This volume is the second in a peer-reviewed series of Proceedings Volumes from the Calgary History of Medicine Days conferences, produced by Cambridge Scholars Publishing. The History of Medicine Days is a two day, national conference held annually at the University of Calgary, Canada, where undergraduate and early graduate students from across Canada, the US, the UK and Europe give paper and poster presentations on a wide variety of topics from the history of medicine and health care. The selected 2010 conference papers assembled in this volume particularly comprise the history of Applications of Science to Medicine, Nursing, Public Health, Illness and Disease, Stigma and Gender, Neurology and Psychiatry, and Eugenics. The 2010 keynote address was delivered by Distinguished Professor of the History of Nursing and Public Health, Dr Geertje Boschma from the University of British Columbia, Vancouver, and is reprinted in the current volume. This volume also includes the abstracts of all 2010 conference presentations and is well-illustrated with diagrams and images pertaining to the history of medicine.
During the 1990's, scientific advances in understanding the mechanisms and pathophysiology of acute central nervous system injury were offset by a history of disappointing results from Phase III clinical trials of novel neuroprotective drugs. Numerous novel compounds were "tested, and seemingly fell by the wayside. This book is intended to focus on novel therapies and the unique challenges their intended targets pose for the design and analysis of clinical trials. The authors explore the issues facing research in this area and the strategies that might lead to future success in this critical area of unmet medical need. It represents a compendium of information gained from over 20 years of cl...
This fully updated new edition, which includes 16 new drugs, is the indispensable guide for all mental health prescribers.
This spin-off from Stephen Stahl's new, completely revised, and fully updated fifth edition of the Prescriber's Guide covers the most important drugs in use today for treating depression. Now established as the indispensable formulary in psychopharmacology, easy to navigate and easy to use, the Prescriber's Guide combines evidence-based information with clinically informed guidance to support clinicians in making the most effective prescribing decisions for the good of their patients. Incorporating information on the newest indications, new formulations, new recommendations and new safety data, this edition continues to provide the essential practical support required by anyone prescribing in the field of mental health.
A spin-off of the best-selling Stahl's Prescriber's Guide, covering the most important drugs for treating patients with psychotic illness.
Consists of the proceedings of various congresses on pain.